| Literature DB >> 30726152 |
Prashant K Mishra1, Gudjon Olafsson2, Lars Boeckmann1, Timothy J Westlake1, Ziad M Jowhar1, Lauren E Dittman1, Richard E Baker3, Damien D'Amours4, Peter H Thorpe2, Munira A Basrai1.
Abstract
Evolutionarily conserved polo-like kinase, Cdc5 (Plk1 in humans), associates with kinetochores during mitosis; however, the role of cell cycle-dependent centromeric ( CEN) association of Cdc5 and its substrates that exclusively localize to the kinetochore have not been characterized. Here we report that evolutionarily conserved CEN histone H3 variant, Cse4 (CENP-A in humans), is a substrate of Cdc5, and that the cell cycle-regulated association of Cse4 with Cdc5 is required for cell growth. Cdc5 contributes to Cse4 phosphorylation in vivo and interacts with Cse4 in mitotic cells. Mass spectrometry analysis of in vitro kinase assays showed that Cdc5 phosphorylates nine serine residues clustered within the N-terminus of Cse4. Strains with cse4-9SA exhibit increased errors in chromosome segregation, reduced levels of CEN-associated Mif2 and Mcd1/Scc1 when combined with a deletion of MCM21. Moreover, the loss of Cdc5 from the CEN chromatin contributes to defects in kinetochore integrity and reduction in CEN-associated Cse4. The cell cycle-regulated association of Cdc5 with Cse4 is essential for cell viability as constitutive association of Cdc5 with Cse4 at the kinetochore leads to growth defects. In summary, our results have defined a role for Cdc5-mediated Cse4 phosphorylation in faithful chromosome segregation.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30726152 PMCID: PMC6589903 DOI: 10.1091/mbc.E18-09-0584
Source DB: PubMed Journal: Mol Biol Cell ISSN: 1059-1524 Impact factor: 4.138
FIGURE 1:Cdc5 interacts in vivo with Cse4 in a cell cycle–dependent manner. Strains carrying vector control (Untagged, YMB9325), Cdc5-HA (YMB9326), Cse4-Flag (YMB9327), and Cdc5-HA Cse4-Flag (YMB9328) were grown at 30°C to logarithmic phase and synchronized in G1, S, and G2/M stages of the cell cycle. Cell extracts were prepared for immunoprecipitation experiments using α-Flag agarose antibodies. (A) FACS profiles show DNA content in different stages of the cell cycle. (B) Cell cycle stages were determined based on nuclear position and cell morphology by microscopic examination of at least 100 cells for each sample. Different stages of the cell cycle: G1, S phase (S), and mitosis (G2/M). (C) In vivo interaction of Cdc5 with Cse4 is observed in G2/M cells. Immunoprecipitated proteins were analyzed by Western blotting with α-HA (Cdc5), and α-Flag (Cse4) antibodies. IP-Flag represents immunoprecipitated samples.
FIGURE 2:Cdc5 phosphorylates Cse4 in vitro mediated by its kinase domain. (A) Cdc5 phosphorylates Cse4 in vitro. Kinase assays were carried out in vitro using purified Cse4, Cdc5, and radiolabeled ATP at 30°C for 60 min and products were analyzed by SDS gel electrophoresis followed by Coomassie blue staining and autoradiography of radiolabeled proteins. Purified histone H3 with Cdc5 served as control. (B) Phosphorylation of Cse4 is mediated by the kinase domain of Cdc5. In vitro kinase assays were carried out using purified Cse4, Cdc5, or Cdc5kd (K100M, a kinase-dead variant of Cdc5; Ratsima ] and radiolabeled ATP as described above.
FIGURE 3:Cdc5 phosphorylates Cse4 at its N-terminus in vitro, and contributes to Cse4 phosphorylation in vivo. (A) Cse4 peptides phosphorylated in vitro by Cdc5 were identified by LC-MS/MS. Phosphorylated serines are marked in blue shading. (B) The region containing the phosphorylated serines within the Cse4 (shaded blue) is evolutionarily conserved among yeasts with point centromeres. ClustalW alignment of the Cse4 regions of Sbay = Saccharomyces bayanus, Scer = S. cerevisiae, Sbou = Saccharomyces boulardii, Spas = Saccharomyces pastorianus, Spar = Saccharomyces paradoxus, and Sarb = Saccharomyces arboricola. (C) cse4-9SA mutant is viable. Wild-type strain with CSE4::URA3 (pRB199) was transformed with vector::LEU2 (YMB10341), CSE4::LEU2 (YMB10049), or cse4-9SA::LEU2 (YMB10339). Strains were plated on synthetic medium without or with counterselection for URA3 by 5-FOA and incubated for 7 d at 25°C. (D) The levels of Cse4 and Cse4-9SA are not significantly different at the CEN chromatin. Wild-type (WT; YMB9383) and cse4-9SA (YMB10593) strains were grown in YPD to logarithmic phase at 25°C, and ChIP for endogenously expressed HA-tagged Cse4 or Cse4-9SA was performed using α-HA agarose antibodies. Enrichment of Cse4 or Cse4-9SA at CEN1, CEN3, CEN5, and a negative control (HML) was determined by qPCR and is presented as percentage of input. The average from three biological replicates ± SE is shown. No statistically significant difference was observed between wild-type and cse4-9SA strains (p value ≥ 0.05; Student’s t test). (E) Cse4-9SA protein does not react with αp-Cse4 antibodies. Wild-type strains transformed with GAL1-6HIS-3HA-CSE4 (YMB10426) or GAL1-6HIS-3HA-cse4-9SA (YMB10427) were grown to logarithmic phase of growth in synthetic medium, and gene expression was induced in the presence of galactose plus raffinose (2% each) at 25°C for about four generations of growth. Protein extracts were prepared for affinity purification of Cse4 or Cse4-9SA strains using Ni2+-NTA agarose. Eluted proteins were analyzed by Western blotting. Antibodies used were α-HA (Cse4) and αp-Cse4–specific (pCse4) antibodies (Boeckmann ). (F) Cdc5 contributes to Cse4 phosphorylation in vivo. FACS profiles show G1 synchronization and release into pheromone-free media to enrich cells in metaphase. Wild-type (YMB10986) and cdc5-99 (YMB10987) strains expressing GAL1-6HIS-3HA-CSE4 (pMB1601) were synchronized in G1 (1.5 μM α-factor) in 1× SC –URA galactose plus raffinose (2% each) for 2 h at 25°C. Cells were collected, washed with water, and released into pheromone-free 1× SC –URA galactose plus raffinose (2% each) at 25 and 37°C for ∼110 min (∼70% cells in metaphase). Protein extracts were prepared and affinity purified as described in E. (G) Cell and nuclear morphology of strains from F post-G1 release into pheromone-free media (∼110 min) showing enrichment of cells in the metaphase stage of the cell cycle. The average from three biological replicates ± SD is shown. (H) Western blotting shows a reduction of Cse4 phosphorylation in cdc5-99 at the nonpermissive temperature (37°C). Affinity-purified proteins from strains grown in F were separated on polyacrylamide gels, and transferred to nitrocellulose membranes. Blots were probed with antibodies: α-HA (total Cse4), and αp-Cse4 antibodies (Boeckmann ). Three biological replicates were performed. (I) Quantification of relative phosphorylation of Cse4 from Western blots. Ratio of phosphorylated Cse4 (pCse4) to the total Cse4 levels (Cse4) in wild-type and cdc5-99 strains was calculated. The histogram represents the average of three biological replicates ± SE. **, p < 0.01; Student’s t test.
FIGURE 4:Cdc5-mediated phosphorylation contributes to faithful chromosome segregation and modulates the levels of Mif2 and Mcd1/Scc1 at the CEN chromatin. (A) Errors in chromosome segregation are increased in cse4-9SA mcm21Δ strains. Frequency of CF loss in wild-type (YPH1018), cse4-S33A (YMB10984), cse4-9SA (YMB10337), mcm21Δ (YMB10645), cse4-S33A mcm21Δ (YMB10985), cse4-9SA mcm21Δ (YMB10646), ctf19Δ (YMB10647), and cse4-9SA ctf19Δ (YMB10648) strains was determined using a colony color assay as described in Materials and Methods. At least 1000 colonies from three independent transformants were counted, and the average from three biological experiments ± SE is shown. **, p value < 0.01; *, p value < 0.05; ns = statistically not significant; Student’s t test. (B) The CEN levels of Mif2 and Mcd1/Scc1 are reduced in cse4-9SA mcm21Δ strains. FACS profiles show DNA content representing the G2/M stage of the cell cycle. Wild-type (YMB9695), cse4-9SA (YMB10593), mcm21Δ (YMB10740), and cse4-9SA mcm21Δ (YMB10741) carrying Mcd1-GFP were grown in YPD to logarithmic phase at 30°C and synchronized in G2/M with nocodazole. ChIP was performed using α-Mif2 antibodies and α-GFP sepharose beads (Mcd1/Scc1) as described in Materials and Methods. (C) Enrichment of Mif2 at CEN3, CAR (134 and 261), and non-CAR control region (310) on chromosome III was determined by ChIP-qPCR and is presented as the percentage of input. Average values from three biological replicates ± SE are shown. *, p value < 0.05; ns = statistically not significant; Student’s t test. (D) Western blotting showing expression of Mif2 in strains used in ChIP experiments. Antibodies used were α-Mif2 and α-Tub2 (loading control). (E) Enrichment of Mcd1/Scc1 at CEN3, CAR (134 and 261), and non-CAR control region (310) on chromosome III was determined by ChIP-qPCR and is presented as the percentage of input. The average values from three biological replicates ± SE are shown. **, p value < 0.01; *, p value < 0.05; ns = statistically not significant; Student’s t test. (F) Western blotting showing expression of Mcd1/Scc1 in strains used in ChIP experiments. The antibodies used were α-GFP and α-Tub2 (loading control).
FIGURE 5:Loss of Cdc5 from CEN correlates with the reduction in CEN-associated Cse4 and defects in structural integrity of kinetochores. (A) Expression of Cdc5 is not affected in cdc5-99 mutant grown at the nonpermissive temperature (37°C). Wild-type (YMB9431) and cdc5-99 (YMB9432) were grown to logarithmic phase at 25°C and shifted to the nonpermissive temperature (37°C) for 2.5 h. Whole cell extracts were prepared and Western blots were done using α-Cdc5 and α-Tub2 (loading control) antibodies. (B) Cdc5-99 does not associate with CEN at the nonpermissive temperature (37°C) in cdc5-99 strain. ChIP was performed in strains as described in A using α-Cdc5 antibodies. Enrichment of Cdc5 at CEN1, CEN3, CEN5, and a negative control (6K120) was determined by qPCR and is presented as the percentage of input. The average from three biological replicates ± SE is shown. **, p value < 0.01; ns = statistically not significant; Student’s t test. (C) Cdc5 regulates the levels of Cse4 at the CEN. Wild-type (YMB9383) and cdc5-99 (YMB9175) were grown in YPD to logarithmic phase at 25°C and shifted to the nonpermissive temperature (37°C) for 6 h. ChIP for HA-tagged Cse4 was performed using α-HA agarose antibodies. Enrichment of Cse4 at CEN1, CEN3, CEN5, and a negative control (HML) was determined by qPCR and is presented as the percentage of input. The average from three biological replicates ± SE is shown. *, p value < 0.05; ns = statistically not significant; Student’s t test. (D) Cdc5 is required for the structural integrity of kinetochores. Wild-type (KBY2012) and cdc5-99 (YMB9367) were grown in YPD to logarithmic phase at 25°C and shifted to nonpermissive temperature (37°C) for 6 h. Nuclei were extracted and incubated with 100 units of DraI restriction endonuclease at 37°C for 30 min as described in Materials and Methods. DraI accessibility at CEN3 and ADP1 (control) chromatin is shown. The average from three biological experiments ± SE is shown. *, p value < 0.05; ns = statistically not significant; Student’s t test. Right inset: schematic modified from our previous study (Mishra ) for CEN3 and ADP1 regions examined for DraI accessibility.
FIGURE 6:Cell cycle–regulated interaction of Cdc5 with Cse4 is required for cell growth. A synthetic physical interaction (SPI) assay was performed using plasmids expressing Cdc5-GBP, cdc5kd-GBP (kinase-dead version), or GBP alone, which were introduced into Cse4-GFP (internally tagged), Cep3-GFP, and non-GFP strains. (A) The cells from the SPI screen were grown overnight in 1× SC –Leu +Ade with 2% galactose medium at 23°C and imaged using fluorescence microscopy. The GBP-RFP and Cdc5-GBP-RFP signal colocalizes with the GFP signal. Cells with Cse4-GFP and Cdc5-GBP-RFP show multiple Cse4-GFP foci in contrast to Cse4-GFP cells containing GBP-RFP control. (B) Cep3-GFP cells containing either Cdc5-GBP-RFP or GBP-RFP control show normal kinetochore foci; each image is 20.6 µm square. (C) Representative images of the scanned plates from the SPI screen show 16 replicates for each strain (rows) and plasmid (columns) combination. (D) The colony sizes in C were measured and log growth ratios plotted for the GFP and wild-type strains with pCUP1-GBP as controls for each comparison. Error bars indicate SD from the mean. **, p value < 0.01; Student’s t test. (E) The forced association of Cdc5 with Cse4 does not arrest cells at a specific cell cycle stage. Tenfold serial dilutions of wild-type and CSE4-YFP (T664) strains carrying the GAL1-CDC5 (pHT573), GAL1-CDC5∆C-GBP (pHT580), GAL1-cdc5kd∆C-GBP (pHT581), and GAL1-Vector (pHT103) plasmids were spotted onto 1× SC –Leu media containing either 2% glucose (expression OFF) or 2% galactose (expression ON), and grown at 30°C for 2 d. (F) Quantification of the cell cycle stages of the CSE4-YFP (T664) strain carrying either the GAL1-Cdc5∆C-GBP or the GAL1-Vector and GAL1-cdc5kd∆C-GBP control plasmids after growing to logarithmic phase in 1× SC –Leu 2% raffinose media, and then swapped to 1× SC –Leu 2% galactose media for 4 h. The cell cycle stage was assessed by fluorescence microscopy and each cell was counted and given the following cell cycle category: nonbudded cells were categorized as G1 cells, small-budded as S/G2, large-budded cells with two Cse4-YFP foci in the bud neck as metaphase (M), and large-budded cells with completely separated Cse4-YFP foci in the mother and daughter as anaphase/telophase cells. No statistical difference was found between Cdc5∆C-GBP to either control as evaluated by Fisher’s exact test. Error bars indicate 95% confidence interval. (G) cse4-9SD mutant is unable to complement the growth defect of cse4∆ strain. Wild-type strain with CSE4::URA3 (pRB199) was transformed with vector::LEU2 (YMB10341), CSE4::LEU2 (YMB10049), cse4-9SA::LEU2 (YMB10339), or cse4-9SD::LEU2 (YMB10340). Strains were streaked on synthetic medium without or with counterselection for URA3 by 5-FOA and incubated for 6 d at 25°C.
Strains and plasmids used in this study.
| (A) | Genotype | Reference |
|---|---|---|
| YMB9325 | This study | |
| YMB9326 | This study | |
| YMB9327 | This study | |
| YMB9328 | This study | |
| YMB10341 | TianYi Zhang, National Cancer Institute, Bethesda, MD | |
| YMB10049 | TianYi Zhang | |
| YMB10339 | This study | |
| YMB10340 | This study | |
| YPH1018 | Phil Hieter, University of British Columbia, Vancouver, BC, Canada | |
| YMB10337 | This study | |
| YMB10645 | This study | |
| YMB10646 | This study | |
| YMB10647 | This study | |
| YMB10648 | This study | |
| YMB10984 | This study | |
| YMB10985 | This study | |
| YMB9695 | ||
| YMB10593 | This study | |
| YMB10740 | This study | |
| YMB10741 | This study | |
| YMB9431 | This study | |
| YMB9432 | This study | |
| YMB9383 | This study | |
| YMB9175 | This study | |
| KBY2012 | ||
| YMB9367 | This study | |
| W8164-2B | ||
| CEP3-GFP strain | ||
| T548 | This study | |
| BY4742 | Resgen | |
| T664 | This study | |
| YMB10426 | This study | |
| YMB10427 | This study | |
| YMB10986 | This study | |
| YMB10987 | This study |
Primers used in this study.
| Locus | Forward (5′-3′) | Reverse (5′-3′) | Reference |
|---|---|---|---|
| CTCGATTTGCATAAGTGTGCC | GTGCTTAAGAGTTCTGTACCAC | ||
| GATCAGCGCCAAACAATATGG | AACTTCCACCAGTAAACGTTTC | ||
| AAGAACTATGAATCTGTAAATGACTGATTCAAT | CTTGCACTAAACAAGACTTTATACTACGTTTAG | ||
| AACGTCACTTTTTTTCCAGGG | GCAAAGCTAGCTAACGAACAA | ||
| CACAGCGGTTTCAAAAAAGCTG | GGATTTTATTTAAAAATCGAGAGG | ||
| TTGATGAACTTTTCAAAGATGAC | GTCAACGAGTCCTCTCTGGCTA | ||
| ATCCAAATGTGCTCAAGATAGTAGC | CACCAAACAACATTTACTAGCAGTG | ||
| CCGATGGTTAGGATTTCCAACG | GGTTTTCAGAACAGAATGGGGC | ||
| TTGCCACAGCCACAGATATAACTG | GATGGACAAAGCGTTGTATCCG | ||
| TCTCGGAATTTATCATGACCCAT | AAACCCTGCACACATTTCGT |